skip to Main Content

Market Access and Health Economics Specialism

Decideum is the leading consultancy in the UK offering market access and HTA services to biotech and pharmaceutical companies. We have worked on over 200 NICE technology appraisals, including over 25 appeals, as well as numerous others with HTA bodies across Europe.

Decideum provides unrivalled advice in health technology appraisal, pricing & reimbursement and health economics.

Decideum offers complete planning and strategic services across the entire market access lifecycle.

Our market access support covers:

  • Health technology appraisals and appeals support
  • Pricing and reimbursement
  • Product launches and licensing
  • Commercial strategy building
  • NHS and clinical engagement
  • Advisory board facilitation
  • Product uptake programmes to encourage market growth and protect market share
  • Stakeholder campaigns and coalition building
  • Health economics and outcomes research
  • Evidence-base and value dossier development

We also work on implementation programmes for NICE clinical guidelines, Quality Standards, interventional procedures and public health guidance.

Decideum operates in partnership with Cogentia Healthcare to offer a complete suite of HTA services to clients from submission development through to HTA assessment and appeals process.

  • Health Technology Assessment
  • Commercial strategy
  • Environment conditioning
  • Health economics and outcomes research

Whether you are considering exploring a new market, require assistance in the production of a research report, desire survey or perception data to support your commercial decisions, or need further information on a throwaway comment picked up during a meeting, Decideum research can provide the solution.

  • Local product uptake (market growth/share)
  • Advisory boards
  • Market research
  • Clinical engagement

Go back to Our Work page

Back To Top